Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?

Colistin is administered as its inactive prodrug colistimethate (CMS). Selection of an individualized CMS dose for each patient is difficult due to its narrow therapeutic window, especially in patients with chronic kidney disease (CKD). Our aim was to analyze CMS use in patients with CKD. Secondary...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorli, Luisa, Luque, Sonia, Li, Jian, Rodríguez, Eva, Campillo, Nuria, Fernandez, Xenia, Soldado, Jade, Domingo, Ignacio, Montero, Milagro, Grau, Santiago, Horcajada, Juan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384574/
https://www.ncbi.nlm.nih.gov/pubmed/30717123
http://dx.doi.org/10.3390/molecules24030530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384574/
https://www.ncbi.nlm.nih.gov/pubmed/30717123
http://dx.doi.org/10.3390/molecules24030530

Ejemplares similares